Integer Holdings Corporation (NYSE:ITGR – Get Free Report) insider Andrew Senn sold 9,408 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total value of $1,188,230.40. Following the transaction, the insider directly owned 5,405 shares in the company, valued at $682,651.50. The trade was a 63.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Integer Stock Up 0.0%
Shares of Integer stock opened at $126.06 on Friday. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $126.79. The company has a market cap of $4.28 billion, a P/E ratio of 34.44, a P/E/G ratio of 2.40 and a beta of 0.62. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. The stock has a 50-day moving average price of $114.21 and a 200 day moving average price of $97.28.
Integer (NYSE:ITGR – Get Free Report) last released its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22. The company had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.The business’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.55 EPS. As a group, analysts expect that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on ITGR
Institutional Investors Weigh In On Integer
Several institutional investors and hedge funds have recently modified their holdings of the business. EverSource Wealth Advisors LLC boosted its holdings in Integer by 48.1% in the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 117 shares in the last quarter. Kestra Advisory Services LLC lifted its position in shares of Integer by 0.6% in the fourth quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock worth $1,680,000 after buying an additional 136 shares during the last quarter. Orion Porfolio Solutions LLC lifted its position in shares of Integer by 1.4% in the second quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after buying an additional 138 shares during the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of Integer by 4.7% in the second quarter. Sequoia Financial Advisors LLC now owns 3,180 shares of the medical equipment provider’s stock worth $297,000 after buying an additional 142 shares during the last quarter. Finally, Lido Advisors LLC boosted its stake in shares of Integer by 5.5% during the 4th quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after acquiring an additional 151 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.
Integer Company Profile
Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.
Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.
Featured Articles
- Five stocks we like better than Integer
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
